Diclectin

TORONTO, ON- APRIL 23 - A physicians wanted safety and efficacy information on a popular morning sickness drug Diclectin, that doctors like him routinely prescribe to pregnant women. He sent in an ATIP to Health Canada, and a year later, and only after the regulator sat down with the drug company to decide on what to redact, the doctor got some but not all the information he required. This is a story about secrecy and a drug company's influence over what information doctors and vulnerable patients are allowed to have. April 23, 2015 (David Cooper/Toronto Star via Getty Images)
TORONTO, ON- APRIL 23 - A physicians wanted safety and efficacy information on a popular morning sickness drug Diclectin, that doctors like him routinely prescribe to pregnant women. He sent in an ATIP to Health Canada, and a year later, and only after the regulator sat down with the drug company to decide on what to redact, the doctor got some but not all the information he required. This is a story about secrecy and a drug company's influence over what information doctors and vulnerable patients are allowed to have. April 23, 2015 (David Cooper/Toronto Star via Getty Images)
Diclectin
ライセンスの購入
どんな用途に素材を使えますか?
¥19,800
JPY
Getty ImagesDiclectin, ニュース写真Diclectin, ニュース写真Diclectin Getty Imagesでは、高品質、高解像度のニュース写真をご利用いただけますProduct #:470840668
¥38,500¥11,000
Getty Images
In stock

詳細

制限:
商業目的またはプロモーション目的で使用する場合は、ゲッティ イメージズのオフィスへお問い合わせください。
クレジット:
David Cooper / 寄稿者
報道写真番号:
470840668
コレクション:
Toronto Star
作成日:
2015年04月23日(木)
アップロード日:
ライセンスタイプ:
リリース情報:
リリースされていません。 詳細情報
ソース:
Toronto Star
オブジェクト名:
DC_042215_0666E
最大ファイルサイズ:
5184 x 3456 px (43.89 x 29.26 cm) - 300 dpi - 2 MB